Market open
Elanco/ELAN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elanco
Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands.
Ticker
ELAN
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
9,550
Website
Elanco Metrics
BasicAdvanced
$7.2B
Market cap
-
P/E ratio
-$2.55
EPS
1.42
Beta
-
Dividend rate
Price and volume
Market cap
$7.2B
Beta
1.42
52-week high
$18.80
52-week low
$8.52
Average daily volume
4.7M
Financial strength
Current ratio
2.928
Quick ratio
1.092
Long term debt to equity
91.939
Total debt to equity
95.523
Interest coverage (TTM)
1.13%
Management effectiveness
Return on assets (TTM)
1.30%
Return on equity (TTM)
-18.78%
Valuation
Price to revenue (TTM)
1.598
Price to book
1.21
Price to tangible book (TTM)
-2.83
Price to free cash flow (TTM)
16.887
Growth
Revenue change (TTM)
3.89%
Earnings per share change (TTM)
1,003.90%
3-year revenue growth (CAGR)
-0.43%
3-year earnings per share growth (CAGR)
18.72%
What the Analysts think about Elanco
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Elanco stock.
Elanco Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Elanco Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Elanco News
AllArticlesVideos
Pomerantz Law Firm Announces the Filing of a Class Action Against Elanco Animal Health Incorporated and Certain Officers - ELAN
Accesswire·14 hours ago
US FDA approves Elanco's treatment for parasitic infections in dogs
Reuters·19 hours ago
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Elanco Animal Health Incorporated For Possible Securities Fraud
Accesswire·6 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Elanco stock?
Elanco (ELAN) has a market cap of $7.2B as of October 08, 2024.
What is the P/E ratio for Elanco stock?
The price to earnings (P/E) ratio for Elanco (ELAN) stock is 0 as of October 08, 2024.
Does Elanco stock pay dividends?
No, Elanco (ELAN) stock does not pay dividends to its shareholders as of October 08, 2024.
When is the next Elanco dividend payment date?
Elanco (ELAN) stock does not pay dividends to its shareholders.
What is the beta indicator for Elanco?
Elanco (ELAN) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.